NCT00290680View on ClinicalTrials.gov

Bortezomib and Celecoxib in Treating Patients With Advanced Solid Tumors

PHASE1CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

March 31, 2005

Primary Completion Date

January 31, 2009

Study Completion Date

January 31, 2009

Conditions
Unspecified Adult Solid Tumor, Protocol Specific
Interventions
DRUG

bortezomib

DRUG

celecoxib

Trial Locations (1)

29425

Hollings Cancer Center at Medical University of South Carolina, Charleston

All Listed Sponsors
lead

Medical University of South Carolina

OTHER

NCT00290680 - Bortezomib and Celecoxib in Treating Patients With Advanced Solid Tumors | Biotech Hunter | Biotech Hunter